GlassScriptPhysician profile
James O L'Esperance
NPI 1922068105
$4,682.49
in general payments reported to CMS, 2019-2025
50 companies · $540 in 2025
The $540 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $588 · 2021: $656 · 2022: $838 · 2023: $709 · 2024: $856 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,104.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $463.38 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Astellas Pharma US INC | $356.44 | 2019-2023 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $264.76 | 2020-2025 | |
| Intuitive Surgical, INC. | $239.61 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $223.52 | 2022-2024 | Lynparza, Keytruda |
| Medtronic USA, INC. | $220.01 | 2019 | |
| Coloplast Corp | $212.72 | 2019-2024 | Porges Coloplast, Speedicath, Isiris Astent Removal Device |
| Dendreon Pharmaceuticals LLC | $195.50 | 2020-2024 | Provenge |
| Endo Pharmaceuticals INC. | $177.15 | 2020-2024 | Xiaflex |
| Procept Biorobotics Corporation | $167.23 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Myovant Sciences INC. | $141.55 | 2021-2022 | |
| Amgen INC. | $139.85 | 2019-2021 | |
| Pfizer INC. | $138.55 | 2019-2022 | |
| Axonics, INC. | $127.74 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $122.93 | 2024 | Exparel |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James L'Esperance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.